Showing results (321-330 of 928) with videos related to
Sort By:
Pageof 93
The Lancet. Diabetes & Endocrinology|March 14, 2014
SYR-472, a novel once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor, in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trialNobuya Inagaki, Hitoshi Onouchi, Hiroki Sano, et al.The Lancet. Diabetes & Endocrinology|March 14, 2014
Brown adipose tissue volume in healthy lean south Asian adults compared with white Caucasians: a prospective, case-controlled observational studyLeontine E H Bakker, Mariëtte R Boon, Rianne A D van der Linden, et al.The Lancet. Diabetes & Endocrinology|March 14, 2014
Effect of a lifestyle intervention on weight change in south Asian individuals in the UK at high risk of type 2 diabetes: a family-cluster randomised controlled trialRaj S Bhopal, Anne Douglas, Sunita Wallia, et al.The Lancet. Diabetes & Endocrinology|January 10, 2017
Laparoscopic Roux-en-Y gastric bypass in adolescents with severe obesity (AMOS): a prospective, 5-year, Swedish nationwide studyTorsten Olbers, Andrew J Beamish, Eva Gronowitz, et al.The Lancet. Diabetes & Endocrinology|May 12, 2015
The sex-specific association between BMI and coronary heart disease: a systematic review and meta-analysis of 95 cohorts with 1·2 million participantsMorgana L Mongraw-Chaffin, Sanne A E Peters, Rachel R Huxley, et al.The Lancet. Diabetes & Endocrinology|May 7, 2015
Non-proteinuric pathways in loss of renal function in patients with type 2 diabetesEsteban Porrini, Piero Ruggenenti, Carl Erik Mogensen, et al.The Lancet. Diabetes & Endocrinology|July 31, 2016
Monogenic autoimmune diseases of the endocrine systemMatthew B Johnson, Andrew T Hattersley, Sarah E FlanaganThe Lancet. Diabetes & Endocrinology|July 19, 2016
Using social and mobile tools for weight loss in overweight and obese young adults (Project SMART): a 2 year, parallel-group, randomised, controlled trialJob G Godino, Gina Merchant, Gregory J Norman, et al.The Lancet. Diabetes & Endocrinology|May 31, 2015
Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control studyDanish Saleheen, Robert Scott, Sundas Javad, et al.The Lancet. Diabetes & Endocrinology|June 15, 2015
New insights into the controversy of adrenal function during critical illnessEva Boonen, Stefan R Bornstein, Greet Van den BerghePageof 93